Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2018OncotargetOpen Access

Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMaurizio CavallariOspedale dell' AngeloFCFrancesco CavazziniArcispedale Sant'AnnaABAntonella BardiUniversity of Ferrara

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cavallari et al. (2018) studied this question.

synapsesocial.com/papers/69dbe3d5eb8801008ea3c1echttps://doi.org/10.18632/oncotarget.26146
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL2011 · 191 citations
  2. 2DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status2010 · 1,056 citations
  3. 3“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”2016 · 8 citations
  4. 4Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first‐line chronic lymphocytic leukemia2016 · 40 citations